Study on biopharmaceutics classification and oral bioavailability of a novel multikinase inhibitor NCE for cancer therapy. - Wikidata - wikimedia - TriplyDB

Study on biopharmaceutics classification and oral bioavailability of a novel multikinase inhibitor NCE for cancer therapy.

Study on biopharmaceutics classification and oral bioavailability of a novel multikinase inhibitor NCE for cancer therapy.

http://www.wikidata.org/entity/Q33755520

about

Study on biopharmaceutics classification and oral bioavailability of a novel multikinase inhibitor NCE for cancer therapy.

http://www.wikidata.org/entity/Q33755520

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Study on biopharmaceutics clas ...... ibitor NCE for cancer therapy.

@ast

Study on biopharmaceutics clas ...... ibitor NCE for cancer therapy.

@en

type

label

Study on biopharmaceutics clas ...... ibitor NCE for cancer therapy.

@ast

Study on biopharmaceutics clas ...... ibitor NCE for cancer therapy.

@en

prefLabel

Study on biopharmaceutics clas ...... ibitor NCE for cancer therapy.

@ast

Study on biopharmaceutics clas ...... ibitor NCE for cancer therapy.

@en

P1433

Q33755520-26DA68F9-1BE5-4116-865B-9544C71CDC86

P1476

Q33755520-7748FE49-6B20-4A59-B8DF-2BE07503BB15

P2093

Q33755520-0228C0A2-5948-4795-BFD0-7AE54D8EC9B2

Q33755520-0F536F4C-80A1-472E-B7A5-D71076D61396

Q33755520-27117639-F58D-4FC8-A1A4-957D37D59DF2

Q33755520-28B5B9F8-6F2A-4028-9112-0E9C5D27A047

Q33755520-2DC58CDF-1269-4C6A-9EE3-C6F0239D5330

Q33755520-427A574F-F532-4B5F-927F-4C4668BE0C77

Q33755520-4C833D6A-0149-4CA2-BD67-8F07E0F18BD5

Q33755520-740D5847-1B15-4491-8CCE-97F2BEDEC52F

Q33755520-767A8C6A-92F5-4503-87B8-CF1AD12B50DF

Q33755520-87794BB4-9AF5-4F9A-A97F-BA10A358516F

P2860

Q33755520-06A926BF-9AE4-4FDA-A093-A55CC6E57C4F

Q33755520-07851228-2DEE-4ACA-90AB-18F6559ABAB1

Q33755520-0F66B825-A3B8-473B-ADA9-380D11DE794E

Q33755520-13121EC9-6D12-4795-BB53-49896B522585

Q33755520-25B43A0F-7B3D-4552-85D3-2B89E1FB326D

Q33755520-2F3587DE-8AB9-4D04-9E25-94A05A3A8CC9

Q33755520-59551A9A-67D0-4047-9660-BB7EF6E8476D

Q33755520-5968721B-846C-4273-A115-C06B0D61F5A4

Q33755520-60A5E0CD-0DFE-4E24-BB1C-8B817B93BEA8

Q33755520-61CF572C-8B77-4D98-ABCA-D932CE71E5D3

P304

Q33755520-48899828-3845-4BD4-B28E-3F5198B7C868

P31

Q33755520-19FB9190-8821-4818-89DB-B41A56DEA2B2

P356

Q33755520-93CD0EF1-3826-4BCC-A86F-CBAB91039B51

P407

Q33755520-0C9B6DC7-058E-4BC4-B555-DDB741F6CF70

P433

Q33755520-6407A551-E200-474E-8CD5-6F13B7D457BE

P478

Q33755520-4C0A9C5A-311F-40C1-8930-7C0584E35C29

P577

Q33755520-F645DD15-73FA-4E6B-B25C-86C4BFA823DA

P5875

Q33755520-AD545193-95CE-44A7-B8D6-3FA55CDBCE2E

P698

Q33755520-28DCAD0C-44F3-47C4-BD73-2CF01140857B

P932

Q33755520-C1945A59-B6A4-4A76-B0E8-98A4CFAD793A

P356

P1433

International Journal of Molecular Sciences

P1476

Study on biopharmaceutics clas ...... ibitor NCE for cancer therapy.

@en

P2093

Chang-Yang Gong

http://www.w3.org/2001/XMLSchema#string

Chun-Mei Fan

http://www.w3.org/2001/XMLSchema#string

Jin-Kun Zhang

http://www.w3.org/2001/XMLSchema#string

Jun Zeng

http://www.w3.org/2001/XMLSchema#string

Ke Ren

http://www.w3.org/2001/XMLSchema#string

Luo-Ting Yu

http://www.w3.org/2001/XMLSchema#string

Xiang-Rong Song

http://www.w3.org/2001/XMLSchema#string

Xuan He

http://www.w3.org/2001/XMLSchema#string

Yang Yang

http://www.w3.org/2001/XMLSchema#string

Ying-Ju He

http://www.w3.org/2001/XMLSchema#string

P2860

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models.

In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.

Comparison between permeability coefficients in rat and human jejunum.

Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.

Application of method suitability for drug permeability classification.

Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification

SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.

Predicting human intestinal permeability using single-pass intestinal perfusion in rat.

Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man.

P304

7199-7212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS15057199

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261955453

http://www.w3.org/2001/XMLSchema#string

P698

24776763

http://www.w3.org/2001/XMLSchema#string

P932

4057667

http://www.w3.org/2001/XMLSchema#string